Physician profile
Melanie M Sov
NPI 1326638792
$4,580.43
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,505 · 2022: $1,492 · 2023: $346 · 2024: $113 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,250.51 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $930.47 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $355.15 | 2021-2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $287.30 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $262.09 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $253.26 | 2021-2023 | Rebyota |
| Qol Medical, LLC | $243.13 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $194.52 | 2021-2022 | |
| Janssen Biotech, INC. | $147.51 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $123.48 | 2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $107.75 | 2023 | Terlivaz |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2022 | |
| Gilead Sciences, INC. | $92.25 | 2021 | |
| Celgene Corporation | $78.76 | 2021-2022 | |
| Braintree Laboratories, INC. | $46.89 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $34.62 | 2021 | |
| Ironwood Pharmaceuticals, INC | $32.40 | 2021 | |
| Pfizer INC. | $23.12 | 2021 | |
| Merck Sharp & Dohme LLC | $17.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Sov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.